BTAI fund manager activity
BioXcel Therapeutics, Inc · Nasdaq. Reported by 1 tracked fund manager in their 13F filings, Q2 2025 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Howard Marks - Oaktree Capital Management | Added | 1,380,248 | $1,946,150 | 0.05% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Howard Marks - Oaktree Capital Management | No change | 241,188 | $323,193 | 0.01% | May 20, 2026 |